The Therapeutic Mechanisms of Shenyan Oral Liquid I Against Chronic Kidney Disease Based on Network Pharmacology and Experimental Validation.

Cheng, Xudong; Liang, Guoqiang; Liu, Min; Song, Rujun; Zhou, Lan; Ren, Yan; Huang, Yuyu; Jin, Weimin; Jiang, Chunbo

Cheng, Xudong; Liang, Guoqiang; Liu, Min; Song, Rujun; Zhou, Lan; Ren, Yan; Huang, Yuyu; Jin, Weimin; Jiang, Chunbo.

Afiliación

Cheng X; Suzhou TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, China.
Liang G; Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, China.
Liu M; Nanjing University of Traditional Chinese Medicine, Nanjing, 210000, China.
Song R; Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, China.
Zhou L; Department of Nephrology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, 215000, China.
Ren Y; Department of Nephrology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, 215000, China.
Huang Y; Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, China.
Jin W; Department of Nephrology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, 215000, China.
Jiang C; Department of Nephrology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, 215000, China.

Comb Chem High Throughput Screen ; 2023 Nov 13.

Article en En | MEDLINE | ID: mdl-37961861

Palabras clave

Autophagy; Chronic kidney disease; Network pharmacology; PI3K/AKT signaling; Shenyan Oral Liquid I; Therapeutic mechanisms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Comb Chem High Throughput Screen Asunto de la revista: BIOLOGIA MOLECULAR / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google